SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
NFATc4, a member from the Nuclear Factor of Activated T cells (NFATs) transcription factor family, plays a pivotal role in the development of cardiac hypertrophy. NFATc4 is dephosphorylated by calcineurin and translocated from the cytoplasm to the nucleus to regulate the expression of hypertrophic g...
Main Authors: | Zhenzhen Li, Xiaoying Zhang, Zhen Guo, Yao Zhong, Panxia Wang, Jingyan Li, Zhuoming Li, Peiqing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01519/full |
Similar Items
-
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
by: Sidong Cai, et al.
Published: (2020-12-01) -
SIRT3 improved peroxisomes-mitochondria interplay and prevented cardiac hypertrophy via preserving PEX5 expression
by: Minghui Wang, et al.
Published: (2023-06-01) -
SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300
by: Peiye Shen, et al.
Published: (2016-09-01) -
Epigenetic Reader Bromodomain Containing Protein 2 Facilitates Pathological Cardiac Hypertrophy via Regulating the Expression of Citrate Cycle Genes
by: Zhirong Lin, et al.
Published: (2022-05-01) -
PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy
by: Jingyan Li, et al.
Published: (2016-09-01)